Climb Bio

$Climb Bio(CLYM)$ Climb Bio, Inc.（纳斯达克：CLYM）公布了其单克隆抗体 CLYM116 的新临床前数据。该药物靶向 APRIL（A Proliferation-Inducing Ligand，增殖诱导配体），用于治疗 IgA 肾病（IgAN）。来自非人灵长类（NHP）研究的数据表明，与第一代抗 APRIL 单抗 sibeprenlimab 相比，CLYM116 ...

$Climb Bio(CLYM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001231919-25-000616  Size: 28 KB 网页链接

$Climb Bio(CLYM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-268075  Act: 34  Size: 356 KB 网页链接

$Climb Bio(CLYM)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-088802  Act: 34  Size: 20 KB 网页链接

$Climb Bio(CLYM)$ 2025年10月17日，Climb Bio, Inc. 发布新闻稿，宣布公开了一篇摘要，提供了其创新型抗CD19单克隆抗体 budoprutug 的长期随访临床数据。该药物正在开发用于治疗 B细胞介导的疾病。
来自 I期b阶段临床试验（NCT04652570） 的数据表明，在接受最多四次 budoprutug 给药的四名...

$Climb Bio(CLYM)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001346824-25-000074  Act: 34  Size: 36 KB 网页链接

$Climb Bio(CLYM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-268086  Act: 34  Size: 10 MB 网页链接

$Climb Bio(CLYM)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001193125-25-227090  Size: 27 KB 网页链接

$Climb Bio(CLYM)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-221756  Act: 34  Size: 5 MB 网页链接

$Climb Bio(CLYM)$ 8-K Current report, item 8.01 Accession Number: 0001193125-25-241951  Act: 34  Size: 147 KB 网页链接

$Climb Bio(CLYM)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001193125-25-315108  Act: 34  Size: 296 KB 网页链接

$Climb Bio(CLYM)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-233582  Act: 34  Size: 142 KB 网页链接

$Climb Bio(CLYM)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-25-227025  Act: 34  Size: 240 KB 网页链接

$Climb Bio(CLYM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-227099  Size: 5 KB 网页链接

$Climb Bio(CLYM)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-241629  Act: 34  Size: 166 KB 网页链接